This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. ] i ) at its onset. The calcium sensing receptor (CaSR) is a G-protein coupled receptor, however, the functional involvement of CaSR in diabetic encephalopathy remains unclear. Methods: In this study, diabetic rats were modeled by STZ (50 mg/kg). At the end of 4, 8 and 12 weeks, the CaSR expression in hippocampus was analyzed by Western blot. In neonatal rat hippocampal neurons, the [Ca 2+ ] i was detected by laser scanning confocal microscopy, the production of reactive oxygen species (ROS) in mitochondria, the level of NO and the mitochondrial transmembrane potential were measured by MitoSOX, DAF-FM and JC-1, respectively. Results: Our results showed in hippocampal neurons treated with high glucose, CaSR regulated [Ca 2+ ] i through the PLC-IP3 pathway. CaSR expression was decreased and was involved in the changes in [Ca 2+ ] i . Mitochondrial membrane potential, NO release and expression of p-eNOS decreased, while the production of ROS in mitochondria increased. Conclusion: Down-regulation of CaSR expression was accompanied by neuronal injury, calcium disturbance, increased ROS production and decreased release of NO. Up-regulation of CaSR expression attenuated these changes through a positive compensatory protective mechanism to inhibit and delay diabetic encephalopathy in rats.
Introduction
Diabetes and its associated complications, such as diabetic cardiomyopathy, diabetic nephropathy, and peripheral arterial disease, are known as major health disorders. The epidemic of obesity as well as sedentary lifestyles are projected to result in over 300 million people with diabetes by 2025 [1] . Diabetes increases the risk of nervous system morbidity and mortality. In the last decade, mounting evidence has indicated that type 1 diabetes has adverse effects on central nervous system (CNS) function and cognition [2] .
Diabetic encephalopathy was irst proposed by Nielsen [3] as a diabetic complication and was associated with cognitive de icits and an increased risk of dementia, particularly in the elderly. Cognitive dysfunction in diabetes is characterized by lowered performance in several cognitive domains, especially slowing of mental speed and diminished le ibility. Studies of streptozotocin (STZ)-induced diabetes in rats have demonstrated neurobehavioral de cits using the orris water maze, which is associated with impaired hippocampal long-term potentiation [4] . The multifaceted pathogenesis of diabetic encephalopathy is not yet completely understood, but classical factors such as an imbalance in Ca 2+ homeostasis [5] may contribute to the pathology of diabetic encephalopathy. In the CNS, Ca 2+ acts as a second messenger and is known to be associated with almost every cellular event, including ion channel function, cellular proliferation and migration, neurotransmitter secretion, a on path inding, and dendritic outgrowth. Therefore, the alterations in [Ca 2+ ] i affect the e ecution of Ca 2+ -dependent functions. O idative stress is also considered to regulate the pathogenesis of diabetic encephalopathy. The brain is especially vulnerable to o idative damage as a result of its high o ygen consumption rate. nder normal physiological conditions, a balance e ists between the production of OS and antio idant mechanisms in the CNS. To ic O 2 -and OH -radicals have been implicated in diabetes because they cause non-speci ic glycation of proteins, pero idation of membrane lipids and protein cross-linking, causing loss of organelle function and cell death [6] . Ca 2+ and OS are involved in the response to diabetic encephalopathy. However, it is still not clear how these two compounds play roles in diabetic encephalopathy. In addition, it has been clearly proven that both OS The calcium-sensing receptor (CaS ) is a member of the protein-coupled receptor ( C ) superfamily [ ]. CaS has been localized to almost all areas of the brain, including the hippocampus [10] . As a C , CaS activation stimulates phospholipase to generate diacylglycerol (DA ) and inositol triphosphate (I 3 ). I 3 can trigger the release of calcium from internal stores while DA activates protein kinases C ( C) [11] .
CaS has been implicated in a variety of functions in neurons, including neuronal growth, synaptic plasticity, migration, differentiation, injury, neurotransmission and neurodegeneration with long-term memory loss in Alzheimer's disease [12] [13] [14] . However, the potential role of CaS in the progress of diabetic encephalopathy has not been e amined.
Neurons are highly specialized for the processing and transmission of cellular signals; they communicate with one another via synapses, where the a on terminal of one cell impinges upon another neuron s dendrite, soma or, less commonly, a on. CaS has been implicated in neuronal growth, as activation of CaS in late fetal sympathetic neurons promoted a onal growth, whereas CaS -de icient or deleted mice failed to e hibit such a change [12] .
In this study, we demonstrated that CaS regulated [Ca 2+ ] i and identi ied its mechanism in hippocampal neurons incubated with high glucose concentrations.
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Materials and Methods
Animals ale istar rats (200 250 g) were purchased from Harbin edical niversity (Heilongjiang, China). All istar rats were 12 16 weeks old. All animal protocols were approved by the Animal Care and se Committee of Harbin edical niversity.
Diabetes model and treatment protocols
Diabetes was induced in rats by tail vein injection of streptozotocin (STZ, 50 mg/kg) dissolved in 0.1 citrate buffer (pH 4.5), whereas the control group was injected with citrate buffer alone by the same route. Blood glucose levels were measured using blood glucose test strips 2 h after STZ injection, and blood glucose levels over 16. mmol/ were considered to indicate diabetes. istar rats were randomly divided into 4 groups including control, diabetic-4 weeks (Dia-4 ), diabetic-weeks (Dia-) and diabetic-12 weeks (Dia-12 ). Blood glucose measurements were repeated after 2 weeks of treatment in each group.
Cell culture and preparation
rimary cultures of neonatal rat hippocampal neurons were prepared by previously described methods [15] . Brie ly, early postnatal rats were decapitated, and the brains dissected from the skull and then transferred into a etri dish with pre-cooled D-Hanks solution. Brains were cut along the midline, and the hippocampus was e tracted from each hemisphere. Hippocampi were incubated in solution of 0.125 crude trypsin (1.5 ml) for 20 minutes at 3 C. This solution was replaced with a 0.125 solution of crude trypsin with Trypsin inhibitor and was incubated for 5 minutes at room temperature. Cells were centrifuged at 1000 r/min for 10 minutes, and then, hippocampi were cultured as monolayers at a density of 4-5×10 
Mitochondrial ROS production
itochondrial OS production was measured using itoSO ed [1 ] . Single rat hippocampi were loaded with 5 mol/ itoSO ed at room temperature for 15 min. itoSO ed luorescence was measured at 5 3 nm following e citation at 4 nm using a Zeiss S 510 inverted confocal microscope.
Analysis of mitochondrial transmembrane potential
Treated neurons (4 h) were washed with cold BS and stained with C-1 (4 g/ml, olecular robes) for 15 min at 3 C in the dark. The data were ac uired using a Zeiss S 510 inverted confocal microscope measuring the levels of green and red luorescence at 514/52 ( -1) and 5 5/5 0 nm ( -2), respectively.
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The luorescent probe DA -( erck, Darmstadt, ermany) was used to detect intracellular NO [1 ] . Treated neurons (4 h) were washed with cold BS and supplemented with 10 DAfor 30 min at 3 C. DAluorescence was e cited at a wavelength of 4 0 nm, while emission was detected with an emission ilter of 52 nm.
Statistical analysis
Data are e pressed as the mean S. . . All data involving multiple groups were analyzed by one-way ANOVA. Differences between individual groups were analyzed using Student's t-test. P<0.05 was considered statistically signi icant.
Results
General features of experimental rats
Some evidence demonstrates that defective adult neurogenesis is present in individuals with diabetes. However, the mechanisms related to depression and cognitive dysfunction in patients with diabetes have not been elucidated. In our study, a type 1 diabetes model was established by intraperitoneal injection of STZ. Compared with the control group, water and food intake and the concentration of glucose were signi cantly increased in the diabetes groups ( ig. 1a). These results suggested that the type 1 diabetes model was successfully established.
Ultrastructural changes in the hippocampus of diabetic rats viewed by transmission electron microscopy and the apoptotic rate of the diabetic hippocampal neurons examined by TUNEL
sing transmission electron microscopy, we showed that sections of rat hippocampus in the control group had normal structures, nuclear chromatin was rich, and there was abundant rough endoplasmic reticulum. Synaptic structure was clear, and the mitochondria were typically intact . In the dia-4 w group, the hippocampal morphological structure was damaged, the neurons arranged loosely, degenerative diseases occurred, the mitochondria were swollen and slightly disrupted. However, small vessel architecture was intact, and a minority of synapses were mi ed together and fused. ith the progression of diabetes, pathological changes gradually became more obvious. In the dia-12 w group, obvious swelling, vacuolating and disruption of mitochondria were observed, and a large number of synapses were destroyed ( ig. 1c). To con rm that diabetes results in apoptosis of hippocampal neurons, we e amined apoptosis using the T N assay in hippocampus. The number of T N -positive hippocampal neurons was low in the control group. The percentages of apoptotic cells in the dia-4 w, the dia-w and the dia-12 w groups were increased relative to the control group ( ig. 1b).
Measurement of CaSR levels in the rat hippocampus and hippocampal neurons, as detected by Western blot
CaS is substantially e pressed within the hippocampus [20] and has been implicated in a variety of functions in neurons. In our study, the e pression of CaS in the rat hippocampus was detected by estern blot ( ig. 2a). The CaS protein content in the hippocampus of rats in the dia-4 w, dia-w and dia-12 w groups were decreased compared to the control group ( P<0.05). These results showed that the e pression of CaS was decreased in the hippocampus of diabetic rats.
To further con irm the role of CaS in hippocampus of diabetic rats, cultured neonatal rat hippocampal neurons were treated with 30 m glucose to mimic cellular diabetic encephalopathy. The levels of CaS protein were detected by estern blot ( ig. 2b). The CaS protein content in H group was decreased compared to the control group (P<0.05). CaS protein levels in the H +Calindol group were increased compared to the H group (P<0.05), while CaS levels in the H +Calhe 231 group were decreased (P<0.05). These results demonstrated that Calindol could up-regulate the e pression of CaS , while Calhe 231 could down-regulate the e pression of CaS . 
Measurement of [
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Measurement of p-CaMKII and CaMKII levels in hippocampal neurons by Western blot
Calmodulin-dependent kinase (Ca II)plays a critical role in mediating calcium-induced dendritic growth in cortical neurons [21] . The levels of phosphorylated Ca II (pCa II) and total Ca II protein in hippocampal neurons were analyzed by estern blot. The data showed that the levels of p-Ca II in the H , H +Calindol, H +Calhe 231 and H + N 3 groups were decreased compared to the control group (P<0.05). Compared to the H group, the p-Ca II levels were increased in the H +Calindol group and decreased in the H +Calhe 231 and H + N 3 groups (P<0.05). Compared to the control group,the level of total Ca II in the H , H +Calindol and H + N 3 groups were increased(P<0.05). The levels of p-Ca II and Ca II in hippocampal neurons from the CaCl 2 group remained nearly unchanged ( ig. 3).
release detection by uorescence and p-e S measurement by Western blot
NO is an essential gas messenger in diverse neural processes such as the regulation of dendrite and dendritic spine morphologies [22, 23] . luorescence was utilized to detect NO generation in hippocampal neurons ( ig. 4a). Compared with the control group, the NO luorescence intensity was lower in the H , H +Calhe 231 and H + -N A groups (P<0.05). In contrast, the H +Calindol group and the H +CaCl 2 group had increased levels of NO compared to the control group and the H group(P<0.05). The levels of phosphorylated eNOS (peNOS) in hippocampal neurons were analyzed by estern blot, which showed that p-eNOS levels in the H group were decreased compared to the control group (P<0.05). Compared with the H group, the e pression of p-eNOS in the H +Calindol group and the CaCl 2 group were increased, while the p-eNOS protein content of the H +Calhe 231 group and the -N A group were decreased (P<0.01) ( ig. 4b). 
The level of ROS measured by MitoSOX Red
Some studies show that mitochondrial dysfunction and subse uent OS production are involved in the development of diabetes. Because hyperglycemia is known to disturb mitochondrial function and because mitochondria are likely the major source of OS, we measured the level of OS using itoSO ed in neonatal rat hippocampal neurons from each group ( ig. 6a). OS production signi icantly increased in the H group compared with the control group (P<0.001). Compared with the H group, luorescence intensity of OS production in the H +Calindol, H +Calhe 231, H + -N A and H +IB groups was clearly decreased (P<0.05).
Measurement of mitochondrial membrane potential by JC-1 staining
In our study, the mitochondrial membrane potential was detected using a membrane potential-speci ic dye, C-1. Healthy non-apoptotic cells maintain a high mitochondrial membrane potential, and e hibits red luorescence. In contrast, unhealthy, apoptotic cells e hibits green luorescence. As seen in ig. 6b, the H group showed a clearly decreased mitochondrial membrane potentialrelative to control neurons , as observed through changes in the amount of green luorescence (P<0.001), whereas the H +Calindol, H + -N A and CaCl 2 groups e hibited increased mitochondrial membrane potential compared to the H group 
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Discussion
Diabetic encephalopathy is a serious D complication. To e plore the molecular mechanisms underlying diabetic encephalopathy, the establishment of a reliable animal model is critical. In this study, intraperitoneal injection of STZ was used to generate a rat diabetes model. ater and food intake and the serum concentration of glucose were signi icantly increased in diabetic model groups compared to the control group, indicating the successful establishment of the diabetic model. ltrastructural injuries and the level of apoptosis in diabetic hippocampal neurons corresponded to the characteristics of diabetic encephalopathy.
To investigate the roles of CaS in the mechanism of diabetic encephalopathy, a cellular diabetes model was established using hippocampal neurons treated with 30 m glucose. Our results suggested that the e pression of CaS signi icantly decreased and was accompanied by a decrease in [Ca 2+ ] i in these neurons. CaS stimulation elicits C-mediated I 3 formation, leading to an elevation in [Ca 2+ ] i [24] . Down-regulation of CaS e pression was involved in rat diabetic encephalopathy. Calindol, a CaS agonist, could attenuate the high glucose effects and maintain the status of the cells. The reduction in the levels of CaS protein caused disturbances in Ca 2+ homeostasis, induced the alteration of a series of downstream signaling pathways, or directly damaged cellular structure through mitochondrial dysfunction. A substantial number of studies have indicated that the destruction of mitochondrial transmembrane potential is one of the earliest events in the apoptotic cascade, as it occurs before the nuclear features of apoptosis become apparent, and once it collapses, cellular damage becomes irreversible. The results of C-1 staining suggested that the ratio of aggregate/monomer in high glucose-treated cells was markedly decreased, whereas 2 Calindol and 2.3 m CaCl 2 could stabilize the mitochondrial transmembrane potential. In recent years, considerable circumstantial evidence has indicated a role for diabetes-induced o idative stress, which is routinely accompanied by diabetic encephalopathy [25] . O idative stress contributes to increased neuronal damage and death through protein o idation, DNA damage, and pero idation of membrane lipids [26] . O idative stress is thought to play a crucial role in the development of memory impairment in diabetes [2 ] . The activation of CaS by Calindol inhibited OS production in a manner similar to IB , an endogenous D inhibitor. Ca II is regulated by the Ca 2+ /calmodulin comple and has been involved in many signaling cascades and is thought to be an important mediator of learning and memory [2 ] .
hen there is insuf icient calcium or calmodulin present to bind to neighboring subunits, auto-phosphorylation does not occur. As greater amounts of calcium and calmodulin accumulate, auto-phosphorylation occurs, leading to persistent activation of the Ca II enzyme for a short period of time [2 ] . N-3 is an effective inhibitor of Ca II activity and autophosphorylation of the -and -subunits of Ca II. In our study, the level of p-Ca II decreased in neurons treated with high glucose. However, the level of p-Ca II increased in the H +Calindol group and decreased in the H +Calhe 231 and H + N 3 groups compared with the H group, appro imating the changes in [Ca 2+ ] i . The level of total Ca II in the high glucose-treated neurons was increased compared to the control group, suggesting a compensatory increase in protein synthesis. The levels of p-Ca II and Ca II in hippocampal neurons in the CaCl 2 group was largely unchanged, suggesting that CaS may improve the status of neurons treated with high glucose through regulating [Ca 2+ ] i. Nitric o ide (NO) is found in biological systems following synthesis from the amino acid -arginine by nitric o ide synthase (NOS). In the brain, in addition to rela ing the cerebral vasculature, NO plays a role as a neurotransmitter. The function of NO in the hypothalamus has been implicated in the learning process and in memory formation [30] . ong-term potentiation ( T ) and long-term depression ( TD) are two major forms of activity-dependent synaptic plasticity in the brain. The NO-c pathway has been implicated in the induction of hippocampal T and TD, which are known to be the predominant mechanisms for learning and memory [31] . /calmodulin-dependent manner [32] . In our study, in addition to decreases in NO in the H group, the levels of p-eNOS were signi icantly decreased compared with the control group. These results were consistent with a change in the e pression of CaS and [Ca 2+ ] i . urthermore, NO and p-eNOS increased upon treatment with Calindol and CaCl 2 but decreased with Calhe 231 and -N A treatment, suggesting that CaS promoted the synthesis of NO in the high glucose environment.
In this study, CaS regulated neurite outgrowth might be related to the levels of pCa II and the production of NO. CaCl 2 had two roles: a CaS agonist and the source of [Ca 2+ ] o . In hippocampal neurons treated with high glucose, Ca 2+ homeostasis was disturbed, but the inding that Calindol treatment was nearly identical to CaCl 2 treatment could demonstrate that CaS might protect hippocampal neurons from the effects of incubation with high glucose through positive compensatory protection to inhibit and delay rat diabetic encephalopathy. Therefore, it may be possible for diabetic patients to use e ogenous CaS agonists such as calcium, magnesium and zinc to ease the symptoms of diabetic encephalopathy.
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